Skip to main content
International
Ask us anything:
  • About
        • About We challenge convention so healthy can be possible for all
        • Our Story
          • Amneal at-a-glance
          • Our Founders
        • Our Purpose & Commitments
        • Our Culture
          • Learn, Lead, Succeed
          • Our Culture in Action
        • Our Milestones
        • Leadership
          • Executive Leadership
          • Board of Directors
        • Locations
        • Responsibility
          • Patient Assistance Programs
          • Product Donations
          • National & Local Philanthropy
          • Compliance and Ethics
        • Awards & Recognition
        • Amneal About
  • Products
        • Products We produce quality generic, specialty and biosimilar medicines
        • Our Portfolio
          • Generic Products
          • Specialty Products
          • Product Catalog
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
        • Amneal Products
  • Research & Development
        • Research & Development We invest significantly in new product development
        • Generics R&D
        • Specialty R&D
          • Drug Delivery Technologies
        • Product Partnering
        • Amneal Research and Technology
  • Investors
        • Investors Become an Informed Investor
        • Amneal Investors
  • News
  • Careers
        • Careers Join our quest to make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
        • Amneal Careers
  • Contact
  • Customer Login
Amneal Pharmaceuticals
  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds

Home Home  >  News  >  Press Releases

  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds
Normal
Press Release RSS Feed (opens in new window)
Press release year list 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Apr 15, 2021
Amneal to Report First Quarter 2021 Results on May 7, 2021
Apr 05, 2021
Amneal Completes Acquisition of Kashiv Specialty Pharmaceuticals
Feb 26, 2021
Amneal Receives Approval for Generic Version of Ortho Evra®
Feb 26, 2021
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 22, 2021
Amneal to Virtually Participate at Upcoming Investor Conferences
Feb 04, 2021
Amneal to Report Fourth Quarter & Full Year 2020 Results on February 26, 2021
Jan 12, 2021
Amneal to Acquire Substantially All of Kashiv Specialty Pharmaceuticals
Jan 08, 2021
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA
Jan 05, 2021
Amneal to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference

Investor Faq

Get answers to important investor relation questions.

More

Investor Tools

  • Email Alerts
  • RSS Feeds
  • Email Page

IR Contact

Get answers to your investor relation questions.

More
  • Privacy Policy
  • Copyright & Legal Disclaimer
  • Web Accessibility
© Amneal Pharmaceuticals LLC.
All rights reserved.
Powered By Q4 Inc. 5.55.0.1 (opens in new window)
Back to top